1. Home
  2. VTMX vs SYRE Comparison

VTMX vs SYRE Comparison

Compare VTMX & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

VTMX

Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

N/A

Current Price

$35.96

Market Cap

2.7B

Sector

N/A

ML Signal

N/A

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

N/A

Current Price

$44.20

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VTMX
SYRE
Founded
1998
2013
Country
Mexico
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
VTMX
SYRE
Price
$35.96
$44.20
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$30.50
$55.57
AVG Volume (30 Days)
61.5K
623.4K
Earning Date
01-01-0001
05-19-2026
Dividend Yield
1.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.14
N/A
Revenue Next Year
$9.70
N/A
P/E Ratio
$47.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.30
$10.91
52 Week High
$36.26
$45.76

Technical Indicators

Market Signals
Indicator
VTMX
SYRE
Relative Strength Index (RSI) 75.64 77.65
Support Level $30.07 $14.62
Resistance Level N/A N/A
Average True Range (ATR) 0.90 2.44
MACD 0.35 1.07
Stochastic Oscillator 95.12 88.41

Price Performance

Historical Comparison
VTMX
SYRE

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: